Llwytho...
Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
Tiotropium–olodaterol, formulated in the Respimat soft-mist inhaler, is an inhaled fixed-dose combination (FDC) of a long-acting muscarinic antagonist (LAMA) and a long-acting β(2)-agonist (LABA), commercialized under the name of Spiolto or Stiolto. The efficacy of tiotropium–olodaterol 5–5 μg once...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5167492/ https://ncbi.nlm.nih.gov/pubmed/28008243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S92840 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|